Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 621K | $6.21M | $10.00 | Jun 21, 2021 | Direct |
Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Jun 21, 2021 | 2 | $0 | 4 | Jun 22, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |